While there are still hopes that the early administration of convalescent plasma in mildly ill patients might have some benefit (see NEJM Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults), the use of CP for severely ill patients has consistently underwhelmed.  Source: Avian Flu Diary: RECOVERY Convalescent Plasma Trial Closes Recruitment Of Hospitalized COVID Patients